This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Ucb Biopharma Sprl. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: The Innovations of Matthew Jon Timothy Page
Introduction
Matthew Jon Timothy Page is an accomplished inventor based in Slough, GB. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of neutralising antibodies.
Latest Patents
Matthew holds a patent for "Neutralising antibodies to the major exotoxins TcdA and TcdB." This invention describes the derivation and selection of antibodies capable of neutralising the major exotoxins, TcdA and TcdB. The patent also highlights the novel neutralisation and antigen binding properties of individual monoclonal antibodies and mixtures thereof. He has 1 patent to his name.
Career Highlights
Matthew is currently employed at UCB Biopharma Sprl, where he continues to innovate in the biopharmaceutical sector. His work focuses on developing therapies that can effectively combat serious bacterial infections.
Collaborations
Matthew has collaborated with notable colleagues, including David Paul Humphreys and Daniel John Lightwood. Their combined expertise contributes to the advancement of their research and development efforts.
Conclusion
Matthew Jon Timothy Page is a notable inventor whose work in neutralising antibodies has the potential to impact the treatment of bacterial infections significantly. His contributions to the field exemplify the importance of innovation in biopharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile